Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
The heterogeneity of hypertension phenotypes resulting from environmental-genetic interactions provides a strong rationale for using combination therapies that target different pathophysiological mechanisms.
Hypertension is a multifactorial disease, and there is growing evidence that implicates a range of environmental factors in its aetiology. These include dietary sodium, obesity, alcohol, and stress. Additionally, several genetic abnormalities may predispose an individual to hypertension. The number of hypertensive phenotypes resulting from different environmental-genetic interactions may explain, therefore, why there is marked heterogeneity in response to treatment and why any single antihypertensive agent would be unlikely to control BP in more than 25-50% of patients. This is one rationale for combination therapies in which the component drugs affect different pathophysiological mechanisms.
No takes yet. Share an insight, caveat, or question.
Peter Sever (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: